Medical Devices Acquisitions in Maryland

AMETEK, Inc. has acquired LKC Technologies, a Germantown, Maryland-based maker of portable ophthalmic diagnostic devices, including the RETeval handheld ERG system. The seller was DW Healthcare Partners, which had owned LKC as a portfolio company; AMETEK said the deal expands its ophthalmic product portfolio and complements its Ultra Precision Technologies Reichert business.

UFP Technologies, Inc. (Nasdaq: UFPT) acquired Universal Plastics & Engineering Company, Inc. (UNIPEC) of Rockville, Maryland, and Techno Plastics Industries, Inc. (TPI) of Añasco, Puerto Rico to expand its film and thermoplastic molding capabilities for the medical device market. UNIPEC (≈$5M revenue, $2M EBITDA) and TPI (≈$10M revenue, $1M EBITDA) will bolster UFP's thin-film and injection-molding capacity for implantable and other high-barrier medical applications; the deals were financed with cash and borrowings under UFP's credit facility.

SERB Pharmaceuticals purchased the RSDL (Reactive Skin Decontamination Lotion) kit and related inventory, contracts and operations from Emergent BioSolutions for approximately $75 million, with an additional $5 million contingent milestone payment. The deal includes the Hattiesburg, Mississippi leased manufacturing facility and several site-based employees (who will join SERB), while Emergent's Winnipeg facility will continue to supply bulk lotion under a long-term supply agreement; Emergent said the divestiture supports debt reduction and portfolio rationalization.

DW Healthcare Partners, a healthcare-focused private equity firm, completed an investment in LKC Technologies, maker of the handheld RETeval electroretinography/visual evoked potential device. The transaction positions LKC to scale its diagnostic medical-device business globally under new CEO Dina Dubey as founder Jim Datovech transitions from the CEO role.

Frontier Dental Lab Group has partnered with and made an investment in Friendship Dental Laboratories, a full-service dental laboratory based in Rosedale, Maryland. The transaction, supported by O2 Investment Partners, brings Friendship onto Frontier's multi-site dental lab platform (George Diacoloukas will join Frontier's board) to expand the platform's Mid-Atlantic presence and capabilities.

Halma plc has acquired IZI Medical Products, an interventional radiology medical device manufacturer and distributor, from Shore Capital Partners. The deal — which closed on September 30, 2022 — brings IZI's consumable device portfolio and hospital customer base into Halma's healthcare group to expand capabilities, R&D and international growth opportunities.

Blackrock Neurotech has acquired spatial computing software firm MindX, integrating MindX’s MindOS spatial neurocomputing, AR and AI capabilities with Blackrock’s implantable BCI hardware. The acquisition brings MindX’s founder Julia Brown and her team into Blackrock to accelerate commercialization of a full‑stack BCI platform and bolster patient‑facing software and AI capabilities.

Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.

Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.

Avidity Science, a ShoreView portfolio company, has acquired Lab Products, Inc. and its divisions — Bio Medic Data Systems, Hydropac and Harford Systems — expanding its portfolio of water purification and delivery products, control and monitoring solutions, and vivarium equipment for biomedical research. The transaction is the fifth add-on completed under ShoreView's ownership and is intended to broaden Avidity's product capabilities and geographic presence in the life-science research market.